EA201301170A1 - Улучшенный способ получения рилпивирина - Google Patents

Улучшенный способ получения рилпивирина

Info

Publication number
EA201301170A1
EA201301170A1 EA201301170A EA201301170A EA201301170A1 EA 201301170 A1 EA201301170 A1 EA 201301170A1 EA 201301170 A EA201301170 A EA 201301170A EA 201301170 A EA201301170 A EA 201301170A EA 201301170 A1 EA201301170 A1 EA 201301170A1
Authority
EA
Eurasian Patent Office
Prior art keywords
rilpivirin
hydrochloride
obtaining
improved method
isomer
Prior art date
Application number
EA201301170A
Other languages
English (en)
Other versions
EA024409B1 (ru
Inventor
Мукунд Кешав Гурджар
Голакчандра Сударшан Майкап
Шашикант Гангарам Джоши
Сачин Аравинд Бадхе
Самит Сатиш Мехта
Original Assignee
Эмкьюар Фармасьютикалз Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эмкьюар Фармасьютикалз Лимитед filed Critical Эмкьюар Фармасьютикалз Лимитед
Publication of EA201301170A1 publication Critical patent/EA201301170A1/ru
Publication of EA024409B1 publication Critical patent/EA024409B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/04—Preparation of carboxylic acid nitriles by reaction of cyanogen halides, e.g. ClCN, with organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/34—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring with cyano groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by unsaturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/04—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Настоящее изобретение относится к получению ключевого промежуточного соединения для рилпивирина, а именно гидрохлорида (Е)-4-(2-цианоэтенил)-2,6-диметилфениламина (II) способом, включающим взаимодействие соли тетрафторбората иона диазония 2,6-диметил-4-амино-1-карбоксибензилфениламина (VI) с акрилонитрилом в присутствии ацетата палладия с последующей обработкой кислотой и его последующую конверсию в соль гидрохлорид (II), при этом нежелательного изомера Z имеется менее 0,5%, который дает гидрохлорид рилпивирина, имеющий менее 0,1% изомера Z.
EA201301170A 2011-04-15 2012-04-09 Улучшенный способ получения промежуточного соединения для синтеза рилпивирина EA024409B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1223MU2011 2011-04-15
PCT/IN2012/000246 WO2012143937A2 (en) 2011-04-15 2012-04-09 An improved rilpivirine process

Publications (2)

Publication Number Publication Date
EA201301170A1 true EA201301170A1 (ru) 2014-02-28
EA024409B1 EA024409B1 (ru) 2016-09-30

Family

ID=47041983

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201301170A EA024409B1 (ru) 2011-04-15 2012-04-09 Улучшенный способ получения промежуточного соединения для синтеза рилпивирина

Country Status (10)

Country Link
US (1) US8952155B2 (ru)
EP (1) EP2643294B1 (ru)
JP (1) JP5870183B2 (ru)
KR (1) KR101879468B1 (ru)
AP (1) AP2013006779A0 (ru)
BR (1) BR112013016546A2 (ru)
EA (1) EA024409B1 (ru)
ES (1) ES2604405T3 (ru)
WO (1) WO2012143937A2 (ru)
ZA (1) ZA201302020B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2680146T3 (es) * 2011-09-16 2018-09-04 Hetero Research Foundation Hidrocloruro de rilpivirina
WO2013153162A1 (en) * 2012-04-11 2013-10-17 Sandoz Ag Polymorph of rilpivirine hydrochloride
WO2013153161A2 (en) * 2012-04-11 2013-10-17 Sandoz Ag Novel polymorph of rilpivirine hydrochloride
CZ201532A3 (cs) * 2015-01-21 2015-02-25 Zentiva, K.S. Způsob výroby vysoce čistého Rilpivirinu a jeho solí
CN107162987A (zh) * 2016-03-07 2017-09-15 宜昌人福药业有限责任公司 一种利匹韦林的工业化合成方法及中间体化合物
US20210380540A1 (en) 2018-10-25 2021-12-09 Minakem Process for the preparation of rilpivirine
CN112778214A (zh) * 2021-01-13 2021-05-11 安徽贝克联合制药有限公司 用于合成利匹韦林的中间体、其合成方法和利匹韦林的合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2757543B1 (fr) * 1996-12-23 1999-04-02 Sanofi Sa Procede pour la cristallisation d'un derive de tetrahydropyridine et formes cristallines ainsi obtenues
CN101481356B (zh) * 2002-08-09 2012-07-11 詹森药业有限公司 制备4-[[4-[[4-(2-氰基乙烯基)-2,6-二甲基苯基]氨基]-2-嘧啶基]氨基]苄腈的方法
ES2371442T7 (es) * 2004-09-02 2022-05-12 Janssen Pharmaceutica Nv Sal de 4-[[4-[[4-(2-cianoetenil)-2,6-dimetilfenil]amino]-2-pirimidinil]amino]benzonitrilo

Also Published As

Publication number Publication date
KR101879468B1 (ko) 2018-07-17
KR20130143046A (ko) 2013-12-30
WO2012143937A3 (en) 2013-03-21
WO2012143937A2 (en) 2012-10-26
EP2643294A4 (en) 2014-12-24
ZA201302020B (en) 2014-05-28
AP2013006779A0 (en) 2013-03-31
EA024409B1 (ru) 2016-09-30
US8952155B2 (en) 2015-02-10
JP2014522385A (ja) 2014-09-04
JP5870183B2 (ja) 2016-02-24
US20140275538A1 (en) 2014-09-18
BR112013016546A2 (pt) 2016-09-27
ES2604405T3 (es) 2017-03-06
EP2643294A2 (en) 2013-10-02
EP2643294B1 (en) 2016-08-24

Similar Documents

Publication Publication Date Title
EA201301170A1 (ru) Улучшенный способ получения рилпивирина
EA201400709A1 (ru) Молекула биспецифического антитела
NZ704662A (en) Crystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid
EA201600506A1 (ru) КРИСТАЛЛИЧЕСКИЙ КОМПЛЕКС 1-ЦИАНО-2-(4-ЦИКЛОПРОПИЛБЕНЗИЛ)-4-(β-D-ГЛЮКОПИРАНОЗ-1-ИЛ)БЕНЗОЛА, СПОСОБЫ ЕГО ПОЛУЧЕНИЯ И ЕГО ПРИМЕНЕНИЕ ДЛЯ ПРИГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ
EA201490988A1 (ru) Изолирующее остекление, выгнутое в холодном состоянии
EA201490474A1 (ru) Аминохиназолины в качестве ингибиторов киназ
EA201391318A1 (ru) Твердые формы 3-(5-амино-2-метил-4-оксо-4н-хиназолин-3-ил)пиперидин-2,6-диона и их фармацевтические композиции и применение
EA201892050A1 (ru) Способ получения замещенных 5-фтор-1h-пиразолопиридинов
EA201300604A1 (ru) Соединения, предназначенные для лечения респираторно-синцитиальных вирусных инфекций
BR112013019025A2 (pt) processo para o preparo de 4-amino-3-cloro-5-fluoro-6-(substituído) picolinatos
MX340125B (es) 2-hidroxi-4-(metiltio) butironitrilo estable en almacenamiento.
BR112012030742A2 (pt) ésteres de dialcanolamina quaternários
EA201391554A1 (ru) Способы получения макроциклических депсипептидов и новых промежуточных соединений
WO2013067531A3 (en) Methods of using microrna 195 in providing neuroprotection
EA201270237A1 (ru) Способ получения 1-бензил-3-гидроксиметил-1н-индазола и его производных и необходимые промежуточные соединения, содержащие магний
EA201200514A1 (ru) Применение 4-[этил(диметил)аммонио]бутаноата для лечения сердечно-сосудистых заболеваний
WO2011102640A3 (en) Method for preparing sitagliptin and amine salt intermediates used therein
EA201590116A1 (ru) Способ получения замещенных триазолопиридинов
MY164880A (en) Process for the preparation of isoxazolyl-methoxy-nicotinic acids
BR112012022928A2 (pt) beta-hidroxialquilamidas, processo para sua produção, bem como seu uso
EA200971019A1 (ru) Способы получения (r)-2-метилпирролидина и (s)-2-метилпирролидина и их солей винной кислоты
UA114155C2 (xx) Спосіб одержання іринотекану
WO2014178061A3 (en) A novel process for the preparation of 2-cyano- 3,3- diarylacrylates
BR112014010037A2 (pt) processo para a produção e estabilização de composi-ções de policarbonato modificadas por impacto usando soluções diluídas de compostos ácidos
EA201400022A1 (ru) Способ получения кристаллических форм агомелатина и его новый полиморф

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU